Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Mathai

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
ERJ Open Research|January 23, 2023
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertensionJ Gerry Coghlan, Sean Gaine, Richard Channick, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 3, 2024
Prognostic Value of Echocardiographic Coupling Metrics in Systemic Sclerosis-Associated Pulmonary Vascular DiseaseAbhishek Gami, Vivek P Jani, Hoda Mombeini, et al.
Circulation|January 21, 2018
Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial HypertensionSteven Hsu, Kristen M Kokkonen-Simon, Jonathan A Kirk, et al.
Annals of the American Thoracic Society|January 24, 2015
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertensionLea Ann Matura, Corey E Ventetuolo, Harold I Palevsky, et al.
Annals of the American Thoracic Society|August 4, 2022
Heterogeneity of Lung Function Phenotypes in Sarcoidosis: Role of Race and Sex DifferencesMichelle Sharp, Kevin J Psoter, Aparna Balasubramanian, et al.
Respiratory Medicine|December 9, 2022
Effects of COVID-19 pandemic on the management of pulmonary hypertensionChristine Y Zhou, Sandeep Sahay, Oksana Shlobin, et al.
Plos One|May 1, 2012
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patientsChris Cheadle, Alan E Berger, Stephen C Mathai, et al.
American Journal of Respiratory and Critical Care Medicine|December 18, 2018
Disconnect between Fibrotic Response and Right Ventricular DysfunctionSlaven Crnkovic, Bakytbek Egemnazarov, Rachel Damico, et al.
Circulation. Heart Failure|April 13, 2018
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart DiseaseEmmanouil Tampakakis, Sanjiv J Shah, Barry A Borlaug, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
ERJ Open Research|January 23, 2023
Early selexipag initiation and long-term outcomes: insights from randomised controlled trials in pulmonary arterial hypertensionJ Gerry Coghlan, Sean Gaine, Richard Channick, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|October 3, 2024
Prognostic Value of Echocardiographic Coupling Metrics in Systemic Sclerosis-Associated Pulmonary Vascular DiseaseAbhishek Gami, Vivek P Jani, Hoda Mombeini, et al.
Circulation|January 21, 2018
Right Ventricular Myofilament Functional Differences in Humans With Systemic Sclerosis-Associated Versus Idiopathic Pulmonary Arterial HypertensionSteven Hsu, Kristen M Kokkonen-Simon, Jonathan A Kirk, et al.
Annals of the American Thoracic Society|January 24, 2015
Interleukin-6 and tumor necrosis factor-α are associated with quality of life-related symptoms in pulmonary arterial hypertensionLea Ann Matura, Corey E Ventetuolo, Harold I Palevsky, et al.
Annals of the American Thoracic Society|August 4, 2022
Heterogeneity of Lung Function Phenotypes in Sarcoidosis: Role of Race and Sex DifferencesMichelle Sharp, Kevin J Psoter, Aparna Balasubramanian, et al.
Respiratory Medicine|December 9, 2022
Effects of COVID-19 pandemic on the management of pulmonary hypertensionChristine Y Zhou, Sandeep Sahay, Oksana Shlobin, et al.
Plos One|May 1, 2012
Erythroid-specific transcriptional changes in PBMCs from pulmonary hypertension patientsChris Cheadle, Alan E Berger, Stephen C Mathai, et al.
American Journal of Respiratory and Critical Care Medicine|December 18, 2018
Disconnect between Fibrotic Response and Right Ventricular DysfunctionSlaven Crnkovic, Bakytbek Egemnazarov, Rachel Damico, et al.
Circulation. Heart Failure|April 13, 2018
Pulmonary Effective Arterial Elastance as a Measure of Right Ventricular Afterload and Its Prognostic Value in Pulmonary Hypertension Due to Left Heart DiseaseEmmanouil Tampakakis, Sanjiv J Shah, Barry A Borlaug, et al.
BMC Medicine|October 6, 2020
Insulin-like growth factor binding protein-2: a new circulating indicator of pulmonary arterial hypertension severity and survivalJun Yang, Megan Griffiths, Melanie K Nies, et al.
Pageof 22